Medical Developments International reported AUD21K in Interest Expense on Debt for its fiscal semester ending in June of 2024.


Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Avita Medical AUD 1.35M 230K Jun/2024
Clinuvel Pharmaceuticals 2.43M 414.48K Jun/2024
Dianthus Therapeutics 4.44M 263K Sep/2024
Genetic Signatures AUD 18K 17K Jun/2024
Ionis Pharmaceuticals USD 19M 0 Jun/2025
Medical Developments International AUD 21K 23K Jun/2024
Neuren Pharmaceuticals 0 0 Jun/2024
Organon & Co USD 131M 7M Jun/2025
Paradigm Biopharmaceuticals AUD 4K 2.48K Jun/2024
PYC Therapeutics AUD 6K 30.66K Jun/2024
Tectonic Therapeutic USD 17K 5K Jun/2025
Telix Pharmaceuticals AUD 3.39M 2.92M Dec/2024
Viatris USD 116.6M 1.1M Jun/2025
Xeris Pharmaceuticals USD 7.36M 343K Jun/2025